# A Review on Cardiovascular Outcome Studies of Dipeptidyl Peptidase-4 Inhibitors

CorpusID: 52923138 - [https://www.semanticscholar.org/paper/5b21908591824d928961d6d58b4e2d09adcf2cf5](https://www.semanticscholar.org/paper/5b21908591824d928961d6d58b4e2d09adcf2cf5)

Fields: Medicine

## (s3) cuRRent evIdence Related to occuRRence of heaRt faIluRe of dPP-4
(p3.0) One recent observational study [30] was conducted to compare a risk of hospitalization for CVDs between gliptins with glimepiride using database of Korean National Health Insurance Service of 19,951 in cohort. This study reported that risk of hospitalization for CVDs was found to be decreased among patients with a history of visit for CVDs in the DPP-4 inhibitors versus glimepiride group.
